Transduced endothelial cells expressing high levels of tissue plasminogen activator have an unaltered phenotype in vitro
- 1 January 1993
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 154 (1) , 207-216
- https://doi.org/10.1002/jcp.1041540124
Abstract
Elevated cellular plasminogen activator activity has been associated with significant alterations in the in vitro phenotype of both malignant cell lines and nonmalignant endothelial cells. To examine the role of elevated cellular plasminogen activator activity in the production of altered endothelial cell behavior, bovine coronary artery endothelial cells were transduced with a retroviral vector expressing large amounts of tissue plasminogen activator. Cells transduced with the tissue plasminogen activator vector were compared with both untransduced cells and cells transduced with a control vector in a series of in vitro assays of cellular attachment, proliferation, migration, and invasion. The morphology of the 2 transduced populations was unchanged. There was a small decrease (5–15%) in the horizontal migration rate of both transduced cell populations, as compared with that of untransduced cells. No significant differences were detected among the three cell populations in any of the other assays. We conclude that expression of high levels of tissue plasminogen activator does not specifically affect endothelial cell phenotype in vitro. These data lend support to the hypothesis that elevated plasminogen activator activity is necessary but not sufficient to produce alterations in endothelial cell behavior.Keywords
This publication has 37 references indexed in Scilit:
- Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitorExperimental Cell Research, 1991
- Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cellsExperimental Cell Research, 1991
- Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.The Journal of cell biology, 1990
- Tissue Plasminogen ActivatorNew England Journal of Medicine, 1988
- Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatasesJournal of Cellular Physiology, 1988
- An anticatalytic monoclonal antibody to avian plasminogen activator: Its effect on behavior of RSV-transformed chick fibroblastsCell, 1986
- Human endothelial cells are chemotactic to endothelial cell growth factor and heparin.The Journal of cell biology, 1985
- Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activatorInternational Journal of Cancer, 1981
- Activation of human breast carcinoma collagenase through plasminogen activatorLife Sciences, 1980
- Endogenous Activation of Latent Collagenase by Rheumatoid Synovial CellsNew England Journal of Medicine, 1977